Home/Filings/4/0000950170-25-032638
4//SEC Filing

Smith Kevin Raymond Merrill 4

Accession 0000950170-25-032638

CIK 0001294133other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:41 PM ET

Size

17.6 KB

Accession

0000950170-25-032638

Insider Transaction Report

Form 4
Period: 2025-02-28
Smith Kevin Raymond Merrill
DirectorCEO and President
Transactions
  • Tax Payment

    Common Stock

    2025-03-01$8.33/sh13,700$114,12130,687 total
  • Award

    Restricted Stock Unit

    2025-02-28+90,03690,036 total
    Common Stock (90,036 underlying)
  • Award

    Common Stock

    2025-03-01$8.33/sh+1,500$12,49516,054 total
  • Exercise/Conversion

    Common Stock

    2025-03-01+28,33344,387 total
  • Tax Payment

    Common Stock

    2025-03-01$8.33/sh26,097$217,38858,565 total
  • Award

    Common Stock

    2025-03-01+53,97584,662 total
  • Purchase

    Common Stock

    2025-03-03$8.56/sh+11,709$100,24570,274 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-03-0128,33356,667 total
    Common Stock (28,333 underlying)
Footnotes (8)
  • [F1]Shares acquired through the Company's 2014 Employee Stock Purchase Plan.
  • [F2]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025.
  • [F3]The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023.
  • [F4]The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on November 10, 2023 and vested on March 1, 2025.
  • [F5]Represents the weighted average share price of an aggregate total of 11,709 shares sold in the price range of $8.455 to $8.6298 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F6]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
  • [F7]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
  • [F8]1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.

Documents

1 file

Issuer

Inogen Inc

CIK 0001294133

Entity typeother

Related Parties

1
  • filerCIK 0001802639

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:41 PM ET
Size
17.6 KB